VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹4.98 Cr | ₹2.49 Cr | ₹2.44 Cr | ₹3.14 Cr | ₹2.82 Cr |
What is the latest Contingent Liabilities ratio of VIMTA LABS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹4.98 Cr |
Mar2023 | ₹2.49 Cr |
Mar2022 | ₹2.44 Cr |
Mar2021 | ₹3.14 Cr |
Mar2020 | ₹2.82 Cr |
How is Contingent Liabilities of VIMTA LABS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹4.98 Cr | 100.12 | |
Mar2023 | ₹2.49 Cr | 1.97 | |
Mar2022 | ₹2.44 Cr | -22.22 | |
Mar2021 | ₹3.14 Cr | 11.16 | |
Mar2020 | ₹2.82 Cr | - |
Compare Contingent Liabilities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹3,669.5 Cr | 3.9% | 16.6% | 161% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 3.9% |
16.6% |
161% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses